Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Gerald Erenberg, MD, is a Staff Member in Cleveland Clinic Children’s Hospital Section of Child Neurology.
Dr. Erenberg is a Diplomate of the National Board of Medical Examiners; the American Board of Pediatrics; and the American Board of Psychiatry and Neurology with special competence in Child Neurology. He completed his undergraduate degree at University of Illinois and earned his medical degree from University of Illinois College of Medicine. His post-graduate training includes a pediatric internship and residency at Michael Reese Hospital in Chicago and a pediatric neurology fellowship at Albert Einstein College of Medicine in Bronx, NY, where he received a National Institute of Neurological Diseases and Blindness Special Fellow award.
Dr. Erenberg is a member of several professional organizations. He is Fellow of the American Academy of Pediatrics and Fellow of the American Academy of Neurology, as well as member of the Child Neurology Society.
Dr. Erenberg has secured a number of research grants over the years to study conditions such as seizures, Tourette syndrome, ADHD, and migraines, as well as drug effects on these and other conditions. He has published multiple research articles in peer-reviewed journals, as well as having contributed abstracts and presentations at a number of professional association meetings.
His special interest has been in improving the health and wellbeing of children with Tourette syndrome. He has worked closely with the Tourette Syndrome Association, and he was Chairman of the Association's Medical Advisory Board for over a decade. He continues to see many children with Tourette syndrome, and he has been actively investigating the optimal medical treatment for this complex disorder.
developmental and learning disorders, pediatric neurology, Tourette's Syndrome, attention deficit disorders
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 5/23/2013 the review process regarding Dr. Erenberg's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.